ERS 2019 Introduction
This year’s European Respiratory Society (ERS) Congress in Madrid was, as always, the place to be to get the most recent updates in important areas of pulmonary diseases.
A large observational study from Denmark showed that chronic obstructive pulmonary disease (COPD) patients treated with ß-blockers did not only have fewer hospitalisations but also a lower total mortality compared with COPD patients treated with other antihypertensive drugs.
Different studies have shown that e-cigarettes are not successful aids for smoking cessation. In most cases, e-cigarettes lead to dual use: smokers consume e-cigarettes in addition to conventional cigarettes. Prof. Jørgen Vestbo (member of the ERS Tobacco Control Committee; ...
please login to read the entire article:
You need to register to read the entire article, please do so now.
« Long-term Azithromycin Decreases Exacerbations in Primary Ciliary Dyskinesia Next Article
COPD Patients Derive Clinical Benefit from β-blockers »
Table of Contents: ERS 2019
Holistic View on Asthma
Infectious Respiratory Disease: the Role of Vaccines
Interstitial Lung Disease
Best of the Posters
Novel Developments in Infectious Disease
A New Trial in Pulmonary Vascular Disease
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.